आपके बैज 52W रेंज $13–$28 15% of range विश्लेषक रेटिंग HOLD 6 analysts मूल्य लक्ष्य $25 +69% upside P/E -7.1 ROE -7.4% शुद्ध लाभ मार्जिन -4.2%

USNA स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा

03
मूल्य $14.82
मार्केट कैप (MRQ) $274M
P/E (TTM) -7.1
EPS (TTM) $-2.10
राजस्व (TTM) $927M
ROE (TTM) -7.4%
52W रेंज $13–$28

USNA स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें

04
सीमा
बार

बार ग्रैन्युलैरिटी चयनित अवधि के अनुसार अनुकूलित होती है — बार के लिए ओपन/हाई/लो/क्लोज देखने के लिए चार्ट पर होवर करें।

स्टॉक विभाजन 3
एक्स-डेट स्प्लिट प्रकार
23 नवमबर 2016 2-for-1 फॉरवर्ड
31 अक्टूबर 2003 2-for-1 फॉरवर्ड
4 अगस्त 1998 2-for-1 फॉरवर्ड

USANA Health Sciences, Inc. Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन

05 · wikidata

USANA Health Sciences, Inc., or USANA, is an American direct sales company based in Salt Lake City, Utah. As of 2021, USANA was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 25 countries via a network of independent distributors.

History

In 1992, immunologist and microbiologist Myron Wentz moved his diagnostic testing company, Gull Laboratories, from Salt Lake City to West Valley City, Utah, and spun it into USANA Health Services, a multilevel marketing manufacturer of supplements. Beginning in 1993, Dallin A. Larsen served as USANA's vice president of sales (and later as a consultant to USANA's president and special advisor to the board of directors) before founding the MLM beverage company Monavie in 2005. USANA's products are not available through retail channels, and can only be obtained through one of its brand partnersor by direct order through the company.

On 20 February 2007, Barry Minkow, founder of the Fraud Discovery Institute, distributed a 500-page report to officials at the U.S. Securities and Exchange Commission (SEC), the Federal Bureau of Investigation (FBI), and the Internal Revenue Service (IRS) accusing USANA of operating an illegal pyramid scheme. The SEC conducted an investigation into USANA's business practices in March 2007 and found no evidence of wrongdoing, concluding its inquiry with no enforcement action recommended. Minkow acknowledged that he was shorting USANA's shares, hoping to profit from a drop in the stock price. In April 2007, a class action lawsuit was filed alleging that USANA's common stock had been artificially inflated. In August 2007, USANA was notified by the Securities and Exchange Commission (SEC) that its shares were subject to delisting from the NASDAQ due to its Form 10-Q, and was determined to be in compliance that October.

In January 2008, a shareholder suit was filed with allegations that USANA had misled investors about the sustainability of its growth and business model. The cases were dismissed, and the company was cleared by the U.S. Securities and Exchange Commission after an informal inquiry into the allegations, stating that it did "not intend to recommend any enforcement action by the Commission." Later that year, two Canadian USANA distributors were awarded $7 million in damages for their wrongful dismissal from the company. The firm had terminated their positions in 2003 because it believed the distributor had violated the companies' policies and procedures.

USANA filed suits against Minkow and his company claiming defamation and stock manipulation. USANA dropped the defamation suit and in March 2008 U.S. District Judge Tena Campbell threw out four of the five claims brought by USANA against Minkow ruling that USANA's claims violated California's anti-SLAPP law for suing Minkow for fair criticism and that USANA did not show a reasonable probability of winning on those claims. The remaining charge of stock manipulation was settled in July 2008, when USANA and Minkow reached an undisclosed settlement that included the removal of all USANA-related materials from the Fraud Discovery Institute website, a related Chinese website, and YouTube. Minkow also agreed to never trade in USANA's stock again.

In December 2010, USANA completed the application process to transfer its common stock listing from the NASDAQ National Market System, where it had traded since 1996, to the New York Stock Exchange. The transfer became official at the beginning of 2011. It received drug-establishment registration from the Food and Drug Administration to manufacture over-the-counter drugs later that year. In 2012, 91% of product sales were purchased by associates. The company acquired BabyCare Ltd., a China-based prenatal supplement company, in 2013 and announced plans to build a manufacturing facility in the country.

By 2018, USANA had reported record revenue due to growth in the Asia-Pacific region, though it recorded a 7% drop in net sales during its 2019 annual report. USANA has partnered with HealthCorps on health education for children and, in 2019, the USANA Foundation's Kids Eat program opened a facility to pack and distribute food for childhood hunger in the Utah area. In 2026, the Kids Eat program continued efforts to address childhood food insecurity in Utah by providing food bags to students and allowing businesses, families, and other organizations to sponsor participating schools. It was also announced as the official nutritional partner of the Spartan Race endurance brand in the United States. Its sales for the first quarter of 2020 declined by 2.3 percent compared with 2019 numbers.

The USANA Foundation was founded in 2012 and has provided hundreds of millions of meals in more than 45 countries. Their programs include USANA Kids Eat and the USANA Garden Towers.

In February 2019, the Ministry of Commerce in China suspended operations of all multi-level marketing companies and participants to conduct a 100-day review of the country's health foods industry due to exaggerated advertising claims and questionable products in the unregulated sector. Chinese departments initiated "Hundred Days of Action" to clean up the health market, where 49 products from various companies were revoked, 54 food business licenses of various companies were revoked, 90 business licenses of various companies were revoked, and 465 counterfeit and fake dens were destroyed. 85 companies, including BabyCare Ltd., a USANA subsidiary, signed a declaration to self-discipline and regulate operations, with BabyCare speaking at an event hosted by the Chinese government.

In 2024, USANA acquired a 79% stake in children's health and wellness company Hiya Health in a $260 million transaction, making Hiya a subsidiary of USANA. At the time of the acquisition, Hiya had grown to approximately $100 million in annual sales and offered eight children's health products, including multivitamins, probiotics, iron supplements, and immune support products.

Corporate affairs

Leadership

In 2007, USANA faced repeated controversy after members of its board of directors, medical advisory board and several of its executives made false statements regarding their qualifications, including education and licenses.

Founder Myron Wentz was the company's chief executive officer from 1992 until 2008, when his son, Dave Wentz, succeeded him after working in positions such as president, executive vice president, and senior vice president of strategic development. In 2015, USANA announced that the chief executive officer role would be divided between Wentz and Kevin Guest, with the former taking global operations and the latter, field development and sales. Guest was appointed the sole chief executive officer in November 2016.

Operations

USANA, a multilevel marketing company, sells its products primarily through non-employee Brand Partners, as well as through the Internet. The firm's 2010 income disclosure statement defines "associates" as those who are actively building a business, acting as wholesale buyers, or are new distributors. The firm's 2009 SEC 10-K filing distinguishes between associates and preferred customers. Associates are independent distributors of USANA products and also purchase them for personal use. Preferred customers may purchase products at wholesale prices strictly for personal use and are not permitted to resell or distribute them. As of July 2011, the firm had 222,000 active Associates and 68,000 preferred customers. It manufactured 90% of its products at the Salt Lake City headquarters, which produced more than 22 million tablets each week.

Associates may be eligible to receive commissions based on their own product sales as well as through sales made by any new distributors they recruit. According to documentation from USANA corporate, 87 percent of associates fail to make enough from commissions to recover the cost of their qualifying purchases with 67 percent of all associates making no commission; the top 2.31 percent of associates earns 72.2 percent of the company's commissions. According to a 2011 article published by the Salt Lake City Tribune, the firm's FY09 income disclosure statement indicated that the average yearly income of the company's 165,710 associates, which includes those just starting, was $617, while the "top-of-the-pyramid distributors earn an average of $857,865 annually".

USANA sells nutritional, personal care, and food products through Brand Partners and online channels.

USANA classifies Brand Partners and Preferred Customers in its core nutritional business as active customers. There were 387,000 active customers as of January 2026. In 2025, Brand Partners and Preferred Customers each made up about half of all active customers.

Sponsorships

USANA has been a paid sponsor of various athletic organizations. USANA offers an "Athlete Guarantee Program" to select sponsored athletes. The program permits selected participants to enter into an agreement with the company stipulating that, should an athlete enrolled in the program test positive for a banned substance (included in World Anti-Doping Agency regulations) as a result of taking USANA products, the company will compensate the athlete up to two times his or her current annual earnings up to $1 million USD.

In 2006, USANA signed a co-sponsorship agreement with the WTA Tour and extended it in 2011. The agreement provides athletes with nutritional supplements that are guaranteed to conform to the Tour's antidoping policy. As part of the agreement in 2011, USANA donated $1 to Children's Hunger Fund for every ace scored at a WTA tournament beginning at Wimbledon and continuing through the end of the season. USANA provided its products to 40 athletes at the Turin Olympics and worked with various sports organizations, including the Professional Rodeo Cowboys Association.

In 2003, USANA became the title sponsor of the USANA Amphitheatre, an outdoor amphitheatre based in West Valley City, Utah with a seating capacity of 20,000. In May 2012, United Concerts announced a continued naming rights partnership with USANA Health Sciences through March 2018.

In 2020, USANA became the title partner of U.S. Ski & Snowboard's training and education facility, the Center of Excellence. The facility is a training hub used by Olympians, youth athletes, and various international competitions.

In the lead-up to the 2020 Summer Olympics, USANA announced partnerships with USA Swimming and the USA Skateboarding National Team. It was the official multivitamin sponsor of USA Swimming and official nutritional supplement supplier of USA Skateboarding. The partnerships reportedly extended into multi-year agreements.

Products

USANA produces three product lines: USANA Nutritionals (Cellsentials, Optimizers, and Digestion/Detox nutritional supplements), USANA Diet & Energy (Reset meal replacement shakes, protein bars, and Rev3 energy drinks), and Sensé & Celavive personal care (skin care, skin treatment, and hair & body care products).

USANA Essentials were tested in 2011 by ConsumerLab.com in its Multivitamin and Multimineral Supplements Review of 38 leading multivitamin/multimineral products sold in the U.S. and Canada. The Essentials passed ConsumerLab's test, which included testing of selected index elements, their ability to disintegrate in solution per United States Pharmacopeia guidelines, lead contamination threshold set in California Proposition 65, and meeting U.S. Food and Drug Administration (FDA) labeling requirements.

USANA began using InCelligence Technology in August 2016 and registered it as a U.S. trademark in March 2017. The technology is used in the company's CellSentials nutritional supplement system, including its Core Minerals and Vita-Antioxidant products, which USANA markets as using its InCelligence Complex to support cellular protection and renewal. As of 2019, its products are marketed in the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, the United Kingdom, the Caribbean, Puerto Rico, Philippines, France, China, Spain, Italy, Germany, Romania, Denmark, Colombia and Indonesia.

Reception

From 2004 to 2006, USANA was named on Forbes "200 Best Small Companies" list. In 2007, a Forbes article quoted industry experts and government officials who had raised questions about the cost of USANA's supplements and its business practices. Radio-Canada later aired an investigative report that examined the company's products, pricing and "misleading income claims" made to potential associates concerning revenue. It included hidden-camera footage of recruitment and other sessions, which found one group of associates appeared to violate the company's policies and distributor agreements. This contrasted with the Canadian legal requirements for multi-level marketing companies to provide clear, frequent and complete information about the revenue of the typical participant. In addition, the same group of associates were filmed making recommendations for using USANA products to treat illnesses including leukemia.

John Cloud, senior writer for Time Magazine, evaluated nutritional supplements in which he took a regimen of USANA pills, protein bars, powder drinks and psyllium fiber as recommended by the company's online evaluation. Cloud took a blood test before starting the products to measure levels of calcium, protein, sodium, cholesterol, glucose, and other substances, and was then tested again five months after starting the supplement regimen, which included 3,000 pills at a cost of $1,200. The follow-up test revealed a change in only two values; a 75% increase in vitamin D levels (attributed to the vitamin D3 supplement Cloud had been taking) and a 28 mg/dl increase in high-density lipoprotein, which could not be accounted for. Cloud also experienced a placebo response where that act of taking the supplements made him feel more vigorous despite no physiological reasons being present. This response also led to a 10-lb weight gain, as the belief that he was more vigorous led him to make poorer dietary decisions—a phenomenon referred to as the "licensing effect".

New Zealand government statistician for the Commerce Commission, Murray H. Smith, who served as an expert witness in every pyramid scheme case brought by the Commission preceding 10 years, opined in 2008 that very few USANA distributors are likely to become wealthy, and stated, "you can make a very strong argument that this could be a pyramid scheme." When asked by the National Business Review to review the firm's business structure and compensation plan, it was Smith's opinion, from a statistical not legal standpoint, that the firm demonstrated a number of characteristics commonly occurring in pyramid schemes including that most members recoup less than what they pay to participate; that those at the top of the structure are more likely to make more than those on the bottom of the structure; and that as the company grows it will become harder to recruit others. Smith also noted the company's significant turnover in distributors making it necessary to continually recruit.

स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗

Wikidata ↗

क्षेत्रConsumer products उद्योगConsumer products कर्मचारी1570 देशUS

10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान

06
राजस्व$925M
2016-12-31 → 2026-01-03
EPS$0.58
2016-12-31 → 2026-01-03
फ्री कैश फ्लो$9M
2016-12-31 → 2026-01-03
शुद्ध मार्जिन-4.2%
2016-12-31 → 2026-01-03
मूल्यांकन और अनुपात 07–12

मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?

मेट्रिक 5Y रुझान USNA 5Y औसत सहकर्मी माध्यिका निर्णय
P/E (TTM) -7.15Y औसत ≈19.7 ≈19.7 · ·
P/S (TTM) 0.35Y औसत ≈1.0 ≈1.0 1.2 अल्पमूल्यित
P/B (MRQ) 0.55Y औसत ≈2.3 ≈2.3 2.4 अल्पमूल्यित
मूल्य / FCF (TTM) -16.85Y औसत ≈20.5 ≈20.5 · ·
मूल्य / नकदी प्रवाह (TTM) -157.25Y औसत ≈13.5 ≈13.5 16.8 उचित मूल्य
मूल्य / मूर्त पुस्तक (MRQ) 0.75Y औसत ≈3.0 ≈3.0 · ·

सहकर्मी माध्यिका को प्रति मीट्रिक मानकीकृत आधार पर गणना की जाती है और यह हमेशा इस स्टॉक के लिए दिखाए गए TTM/MRQ आधार से मेल नहीं खा सकती है।

मान · ≈ 5Y औसत · उद्योग माध्य · माध्य के सापेक्ष निर्णय

Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि

14
औसत आश्चर्य -21.9%
अगली रिपोर्ट अक्ट 19, 2026
Periodरिपोर्टEPS ActualEPS अनुमानआश्चर्य
30 जून 2026 जुल 20, 2026 $-0.07 $0.44 -116.0%
31 मार्च 2026 $0.61 $0.45 35.9%
31 दिसमबर 2025 $0.60 $0.42 43.5%
30 सितमबर 2025 $-0.15 $0.48 -131.3%
30 जून 2025 $0.74 $0.55 34.4%
31 मार्च 2025 $0.73 $0.71 2.2%

पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह

15
आय विवरण 18
मेट्रिक रुझान 202520242023202220212020201920182017201620152014
Revenue $925M$855M$921M$999M$1.19B$1.13B$1.06B$1.19B$1.05B$1.01B$918M$790M
Cost of Revenue $201M$161M$177M$194M$218M$209M$188M$201M$179M$180M$160M$141M
Gross Profit $724M$693M$744M$805M$969M$926M$873M$989M$868M$826M$759M$650M
R&D Expense $11M$12M$11M$12M$11M$11M$10M$10M$9M$9M$6M$5M
SG&A Expense $337M$263M$257M$262M$279M$261M$268M$275M$265M$234M$209M$185M
Operating Expenses $687M$627M$651M$697M$798M$749M$727M$800M$735M$687M$617M$534M
Operating Income $37M$66M$93M$108M$170M$176M$146M$188M$133M$139M$142M$116M
Interest Expense ··$262.0K$192.0K$57.0K$507.0K$66.0K$36.0K$46.0K$444.0K$15.0K$129.0K
Interest Income $2M$11M$10M$4M$3M$3M$5M$4M$2M$1M$1M$500.0K
Other Non-op $3M$-1M$7.0K$-3M$-2M$-571.0K$-335.0K$-1M$-3.0K$-1M$-174.0K$-820.0K
Pretax Income $42M$76M$102M$109M$171M$178M$150M$192M$135M$139M$143M$116M
Income Tax $30M$34M$39M$39M$54M$53M$50M$65M$72M$39M$48M$39M
Net Income $11M$42M$64M$69M$117M$125M$101M$126M$63M$100M$95M$77M
EPS (Basic) $0.58$2.20$3.31$3.60$5.78$5.89$4.44$5.24$2.57$4.14$3.72$2.90
EPS (Diluted) $0.58$2.19$3.30$3.59$5.73$5.86$4.41$5.12$2.53$3.99$3.59$2.80
Shares (Basic) 18,535,00019,103,00019,250,00019,254,00020,146,00021,156,00022,644,00024,105,00024,349,00024,185,00025,460,00026,443,000
Shares (Diluted) 18,574,00019,162,00019,345,00019,310,00020,343,00021,256,00022,818,00024,642,00024,708,00025,047,00026,355,00027,377,000
EBITDA $70M$81M$106M$121M$183M$190M$161M$205M$149M$152M$152M$125M
बैलेंस शीट 26
मेट्रिक रुझान 202520242023202220212020201920182017201620152014
Cash & Equivalents $158M$182M$330M$288M$240M$312M$235M$214M$247M$176M$143M$111M
Receivables $4M···········
Inventory $103M$70M$61M$67M$98M$90M$69M$82M$63M$65M$66M$45M
Prepaid Expense $23M$28M$26M$29M$27M$23M$26M$33M$30M$37M$35M$35M
Other Current Assets $5M$5M$6M$7M$4M$5M$5M$7M$5M$6M$5M$6M
Current Assets $288M$279M$418M$384M$365M$425M$329M$392M$340M$278M$244M$191M
PP&E (Net) $94M$95M$100M$98M$102M$100M$95M$92M$103M$101M$88M$71M
PP&E (Gross) ··$212M$210M$211M$199M$181M$178M$177M$164M$120M$114M
Accum. Depreciation $135M$130M$129M$125M$122M$116M$105M$96M$86M$76M$71M$64M
Goodwill $138M$144M$17M$17M$18M$17M$17M$17M$17M$17M$17M$18M
Intangibles $133M$152M$30M$32M$30M$31M$30M$32M$35M$34M$38M$41M
Other Non-current Assets $62M$59M$55M$55M$58M$62M$43M$18M$21M$22M$25M$24M
Total Assets $743M$748M$633M$597M$578M$641M$517M$554M$519M$471M$423M$351M
Accounts Payable $17M$12M$10M$11M$14M$18M$13M$10M$12M$9M$10M$8M
Accrued Liabilities $10M$14M$10M·········
Current Liabilities $129M$140M$119M$144M$161M$168M$136M$149M$141M$138M$131M$109M
Capital Leases $12M$10M$5M$8M$10M·$17M·····
Deferred Tax $5M$4M$5M$4M$7M$12M$10M$13M$14M$5M$10M$11M
Other Non-current Liabilities $23M$18M$12M$14M$14M$19M$19M$1M$1M$1M$1M$1M
Total Liabilities $157M$162M$136M·········
Common Stock $18.0K$19.0K$19.0K$19.0K$19.0K$21.0K$22.0K$24.0K$24.0K$24.0K$25.0K$13.0K
Retained Earnings $466M$479M$445M$392M$345M$383M$306M$330M$288M$265M$215M$166M
AOCI $-16M$-23M$-14M$-13M$458.0K$-4M$-14M$-10M$-1M$-12M$-4M$2M
Stockholders' Equity $533M$532M$497M$434M$395M$442M$352M$391M$363M$325M$281M$230M
Liabilities + Equity $743M$748M$633M$597M$578M$641M$517M$554M$519M$471M$423M$351M
Shares Outstanding 18,281,00019,064,00019,130,00019,206,00019,393,00021,038,00021,655,00023,567,00024,024,00024,485,00024,976,00025,266,000
नकदी प्रवाह 16
मेट्रिक रुझान 202520242023202220212020201920182017201620152014
D&A $33M$15M$13M$13M$13M$14M$15M$17M$16M$13M$10M$9M
Stock-based Comp $14M$15M$15M$13M$14M$14M$16M$15M$15M$17M$11M$10M
Deferred Tax $-7M$-7M$-3M$-7M$-3M$-2M$-4M$607.0K$19M$-4M$-3M$-1M
Amort. of Intangibles $19M$2M$2M$2M$1M$1M$1M$2M$1M$2M$900.0K$431.0K
Restructuring $6M$0$0·········
Other Non-cash $-28M$-3M$-18M$15M$-20M$10M$-442.0K$-7M$10M$11M$-2M$11M
Operating Cash Flow $22M$61M$71M$104M$121M$160M$127M$152M$124M$137M$111M$105M
CapEx $14M$10M$14M$10M$13M$15M$17M$11M$13M$33M$24M$20M
Investing Cash Flow $-10M$-213M$-12M$-12M$-14M$-34M$47M$-69M$-13M$-32M$-25M$-16M
Stock Repurchased $28M$9M$12M$25M$178M$57M$150M$105M$50M$65M$61M$139M
Net Stock Activity $-28M$-9M$-12M$-25M$-178M$-57M$-150M$-105M$-50M$-65M$-61M$-139M
Financing Cash Flow $-41M$10M$-14M$-30M$-181M$-59M$-152M$-105M$-50M$-65M$-49M$-113M
Net Change in Cash $-23M$-149M$42M$48M$-72M$78M$20M$-33M$72M$32M$32M$-26M
Taxes Paid $37M$40M$42M·········
Free Cash Flow $9M$51M$56M$94M$108M$145M$110M$141M$111M$104M$88M$85M
Levered FCF ··$56M$93M$108M$145M$110M$141M$111M$104M$88M$85M
लाभप्रदता 8
मेट्रिक रुझान 202520242023202220212020201920182017201620152014
Gross Margin 78.3%81.1%80.8%80.6%81.6%81.6%82.3%83.1%82.9%82.1%82.6%82.2%
Operating Margin 4.0%7.8%10.1%10.8%14.3%15.6%13.8%15.8%12.7%13.8%15.4%14.7%
Net Margin 1.2%4.9%6.9%6.9%9.8%11.0%9.5%10.6%6.0%9.9%10.3%9.7%
Pretax Margin 4.5%8.9%11.1%10.9%14.4%15.7%14.2%16.1%12.9%13.8%15.5%14.6%
EBITDA Margin 7.6%9.5%11.5%12.1%15.4%16.8%15.2%17.2%14.2%15.1%16.5%15.8%
ROA 1.4%6.1%10.4%11.8%19.1%21.5%18.8%23.5%12.6%22.4%24.5%21.3%
ROE 2.0%7.9%13.2%16.4%29.3%30.0%30.2%30.5%17.2%33.0%37.0%31.2%
ROIC 1.9%6.9%11.7%15.8%29.4%28.0%27.8%31.7%16.9%30.8%33.5%33.4%
तरलता और शोधन क्षमता 3
मेट्रिक रुझान 202520242023202220212020201920182017201620152014
Current Ratio 2.22.03.52.72.32.52.42.62.42.01.91.8
Quick Ratio 1.21.32.82.01.51.91.71.41.81.31.11.0
Interest Coverage ··355.2560.52985.8348.12215.05232.02880.5312.29444.1900.0
दक्षता 2
मेट्रिक रुझान 202520242023202220212020201920182017201620152014
Asset Turnover 1.21.21.51.71.92.02.02.22.12.32.42.2
Inventory Turnover 2.32.52.72.32.32.22.52.82.82.82.93.0
प्रति शेयर 5
मेट्रिक रुझान 202520242023202220212020201920182017201620152014
Book Value / Share $29.16$27.91$25.99$22.62$20.37$20.99$16.24$16.60$15.12$13.29$22.49$18.22
Revenue / Share $49.81$44.59$47.61$51.71$58.32$53.38$46.49$48.26$42.39$40.17$69.70$57.74
Cash Flow / Share $1.20$3.18$3.65$5.38$5.96$7.55$5.55$6.17$5.01$5.47$8.46$7.68
Cash / Share $8.66$9.53$17.27$15.02$12.37$14.83$10.84$9.09$10.29$7.18$11.47$8.80
EPS (TTM) $0.58$2.19$3.30$3.59$5.73$5.86$4.41$5.12$2.53$3.99$3.59$2.80
विकास दरें 9
मेट्रिक रुझान 202520242023202220212020201920182017201620152014
Revenue YoY 8.3%-7.2%-7.8%-15.8%4.6%·······
Revenue CAGR 3Y -2.5%-10.4%-6.7%·········
Revenue CAGR 5Y -4.0%···········
EPS YoY -73.5%-33.6%-8.1%-37.4%-2.2%·······
EPS CAGR 3Y -45.5%-27.4%-17.4%·········
EPS CAGR 5Y -37.0%···········
Net Income YoY -74.4%-34.1%-8.0%-40.5%-6.5%·······
Net Income CAGR 3Y -46.3%-28.8%-20.0%·········
Net Income CAGR 5Y -38.7%···········
मूल्यांकन (TTM) 10
मेट्रिक रुझान 202520242023202220212020201920182017201620152014
Revenue TTM $925M$855M$921M$999M$1.19B$1.13B$1.06B$1.19B$1.05B$1.01B$918M$790M
Net Income TTM $11M$42M$64M$69M$117M$125M$101M$126M$63M$100M$95M$77M
Market Cap $355M$680M$1.03B$1.02B$1.96B$1.62B$1.73B$2.71B$1.78B$1.50B$798M$646M
P/E 33.516.316.214.817.713.218.122.529.315.317.818.3
P/S 0.40.81.11.01.71.41.62.31.71.50.90.8
P/B 0.71.32.12.45.03.74.96.94.94.62.82.8
P / Tangible Book 1.42.92.32.75.74.1······
P / Cash Flow 15.911.214.59.816.210.113.717.814.410.97.26.1
P / FCF 41.713.418.310.918.111.215.719.316.114.49.17.6
Earnings Yield 3.0%6.1%6.2%6.8%5.7%7.6%5.5%4.5%3.4%6.5%5.6%5.5%

सबसे हाल की अवधि बाईं ओर · शून्य मान इस प्रकार दिखाए गए हैं ·

वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष

16
मेट्रिक 2026-01-032024-12-282023-12-302022-12-312022-01-01
राजस्व $925M $855M $921M $999M $1.19B
सकल मार्जिन % 78.3% 81.1% 80.8% 80.6% 81.6%
परिचालन मार्जिन % 4.0% 7.8% 10.1% 10.8% 14.3%
शुद्ध आय $11M $42M $64M $69M $117M
तनुकरणित EPS $0.58 $2.19 $3.30 $3.59 $5.73

संस्थागत मालिक (13F) 151 फाइलर्स · $260.7M कुल · तिथि अनुसार 30 सितमबर 2026

17

संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।

धारक 151
धारित मूल्य $260.7M
नई स्थितियाँ 25
बाहर निकली पोजीशन 17
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
नई स्थितियाँ बाहर निकली पोजीशन बढ़ाया घटा हुआ शुद्ध शेयर परिवर्तन
25 (-5 पिछली तिमाही की तुलना में) 17 (+8 पिछली तिमाही की तुलना में) 60 (+21 पिछली तिमाही की तुलना में) 30 (-19 पिछली तिमाही की तुलना में) +1.2M

Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।

संस्था मूल्य शेयर % ट्रैक किए गए 13F का प्रकार
BlackRock, Inc. $33181935 1554189 12.73% शेयर
PZENA INVESTMENT MANAGEMENT LLC $25739282 1205587 9.87% शेयर
RENAISSANCE TECHNOLOGIES LLC $20464402 958520 7.85% शेयर
VANGUARD GROUP INC $18340623 934316 7.03% शेयर
DIMENSIONAL FUND ADVISORS LP $17878705 837426 6.86% शेयर
Nantahala Capital Management, LLC $17295080 810074 6.63% शेयर
VANGUARD CAPITAL MANAGEMENT LLC $10405350 487370 3.99% शेयर
Creative Planning $8923681 417971 3.42% शेयर
AQR CAPITAL MANAGEMENT LLC $8712637 408086 3.34% शेयर
VANGUARD PORTFOLIO MANAGEMENT LLC $7758099 363377 2.98% शेयर
GEODE CAPITAL MANAGEMENT, LLC $6047019 283165 2.32% शेयर
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $5811641 272208 2.23% शेयर
STATE STREET CORP $5577474 261240 2.14% शेयर
Nuveen, LLC $5112835 239477 1.96% शेयर
AMERICAN CENTURY COMPANIES INC $3999880 187348 1.53% शेयर
JACOBS LEVY EQUITY MANAGEMENT, INC $3855105 180567 1.48% शेयर
TWO SIGMA INVESTMENTS, LP $3533724 165514 1.36% शेयर
MORGAN STANLEY $3509150 164363 1.35% शेयर
D. E. Shaw & Co., Inc. $3348427 156835 1.28% शेयर
Allianz Asset Management GmbH $3040219 142399 1.17% शेयर
BRIDGEWAY CAPITAL MANAGEMENT, LLC $2949567 138153 1.13% शेयर
ALGERT GLOBAL LLC $2813033 131758 1.08% शेयर
GOLDMAN SACHS GROUP INC $2631750 123267 1.01% शेयर
UBS Group AG $2474166 115886 0.95% शेयर
LAZARD ASSET MANAGEMENT LLC $2077590 97311 0.80% शेयर
NORTHERN TRUST CORP $2016870 94467 0.77% शेयर
AMERIPRISE FINANCIAL INC $1552893 72735 0.60% शेयर
VANGUARD FIDUCIARY TRUST CO $1549540 72578 0.59% शेयर
Vanguard Global Advisers, LLC $1514569 70940 0.58% शेयर
Empowered Funds, LLC $1499902 70253 0.58% शेयर
TWO SIGMA ADVISERS, LP $1289691 65700 0.49% शेयर
Bank of New York Mellon Corp $1104521 51734 0.42% शेयर
Quantinno Capital Management LP $1072261 50223 0.41% शेयर
BANK OF AMERICA CORP /DE/ $967539 45318 0.37% शेयर
ROYCE & ASSOCIATES LP $884039 41407 0.34% शेयर
DEUTSCHE BANK AG\ $821975 38500 0.32% शेयर
Assenagon Asset Management S.A. $815848 38213 0.31% शेयर
BARCLAYS PLC $777141 36400 0.30% शेयर
STRS OHIO $723765 33900 0.28% शेयर
Skopos Labs, Inc. $673696 38563 0.26% शेयर
HSBC HOLDINGS PLC $672758 31960 0.26% शेयर
Invesco Ltd. $670775 31418 0.26% शेयर
SEI INVESTMENTS CO $641513 30047 0.25% शेयर
XTX Topco Ltd $625320 29289 0.24% शेयर
CITADEL ADVISORS LLC $575617 26961 0.22% शेयर
MILLENNIUM MANAGEMENT LLC $570728 26732 0.22% शेयर
Verdad Advisers, LP $556552 26068 0.21% शेयर
Inspire Investing, LLC $512954 29362 0.20% शेयर
Sanctuary Advisors, LLC $497113 23284 0.19% शेयर
Man Group plc $489854 22944 0.19% शेयर

सभी 151 संस्थागत मालिक दिखाएँ →

कार्यकर्ता और 5%+ मालिक 3 होल्डिंग्स

18

जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।

फाइलर दाखिल किया दांव स्थिति उद्देश्य फाइलिंग
Gull Global Limited, Myron W. Wentz ×11 फाइलिंग 30 मार्च 2026 40.10% संशोधन M&A / बिक्री SEC
Gull Holdings, Ltd., Myron W. Wentz, David A. Wentz, Jacquelyn R. Wentz, Bryan Wentz, Annette Wentz, Paul & Jane Meyer Family Foundation, Paul James Meyer, Alice Jane Meyer, Centre Island Properties, Ltd., Waco Boys Club Foundation, Inc., L-K Marketing Group, LLC, Beagle Irrevocable Asset Trust 23 मई 2008 · प्रारंभिक फाइलिंग · SEC
Paul & Jane Meyer Family Foundation 20 मई 2008 · प्रारंभिक फाइलिंग निष्क्रिय निवेश SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

कंपनी के अंदरूनी सूत्र 38 इनसाइडर्स · 20 अधिकारी · 13 निदेशक

19
अंदरूनी भूमिका अंतिम गतिविधि शेयरों का स्वामित्व खरीद 12m बिक्री 12m नेट 12m
Jim Brown CEO & PRESIDENT 24 जुलाई 2025 M 16934 0 0 $0
Doug G Iiekking CHIEF FINANCIAL OFFICER 27 मई 2026 S 0 0 1 $-100500
Jeffrey Yates Chief Financial Officer 28 अक्टूबर 2010 M 0 0 0 $0
Deborah Woo President of Asia 8 सितमबर 2016 M 1479 0 0 $0
Fred W Cooper President and COO 28 अक्टूबर 2010 M 0 0 0 $0
Walter Noot CHIEF OPERATING OFFICER 27 फ़रवरी 2026 M 9256 0 0 $0
Roy Truett Chief Operating Officer 27 जुलाई 2012 M 0 0 0 $0
Kathryn Michelle Armstrong CHIEF SCIENTIFIC OFFICER 25 जुलाई 2026 M 3471 0 0 $0
Peter Benedict CHIEF INFORMATION OFFICER 25 जुलाई 2026 M 422 0 2 $-144236
Brent Neidig CHIEF COMMERCIAL OFFICER 16 जून 2026 S 0 0 3 $-147749
Paul A. Jones CHIEF PEOPLE OFFICER 8 जून 2026 S 0 0 2 $-231984
Joshua Foukas CHIEF LEGAL OFFICER 7 मई 2026 S 0 0 2 $-170336
David Mulham Mulham CHIEF SALES OFFICER 10 दिसमबर 2025 S 8387 0 1 $-18333
Daniel A. Macuga CHIEF COMMUNICATIONS OFFICER 2 मई 2024 S 0 0 0 $0
Robert A Sinnott CHIEF SCIENTIFIC OFFICER 5 मार्च 2024 S 0 0 0 $0
James Bramble Chief Legal Officer and Sec 5 फ़रवरी 2018 A 2076 0 0 $0
Dave Wentz Co-C.E.O. 16 अगस्त 2016 M 384883 0 0 $0
Rick Stambaugh Chief Information Officer 17 दिसमबर 2015 M 0 0 0 $0
Mark H Wilson E.V.P. of Sales 28 अक्टूबर 2010 M 5000 0 0 $0
Bradford Richardson E.V.P. of Asia Pacific 25 फ़रवरी 2008 S 0 0 0 $0
Xia Ding निदेशक 23 जुलाई 2026 M 8278 0 0 $0
John Turman Fleming निदेशक 23 जुलाई 2026 M 5862 0 2 $-78560
Peggie Pelosi निदेशक 23 जुलाई 2026 M 6061 0 0 $0
Scott J Nixon निदेशक 23 जुलाई 2026 M 11445 0 0 $0
Frederic J Winssinger निदेशक 23 जुलाई 2026 M 9733 0 1 $-38420
Timothy E Wood निदेशक 23 जुलाई 2026 M 11837 0 0 $0
Gilbert A Fuller निदेशक 23 जुलाई 2026 M 1632 0 3 $-60414
Robert Auciaux निदेशक 9 मई 2022 M 8092 0 0 $0
Feng Peng निदेशक 28 अप्रैल 2021 M 755 0 0 $0
Myron W. Wentz निदेशक 4 फ़रवरी 2019 S 9865614 0 0 $0
Jerry G Mcclain निदेशक 4 मार्च 2016 M 0 0 0 $0
Ronald S Poelman निदेशक 8 फ़रवरी 2016 A 0 0 0 $0
Denis E Waitley निदेशक 3 नवमबर 2006 M 0 0 0 $0
Gull Global Limited 10% मालिक 4 फ़रवरी 2019 S 9865614 0 0 $0
GULL HOLDINGS LTD 10% मालिक 1 अप्रैल 2015 J 6491110 0 0 $0
Kevin Guest · 27 फ़रवरी 2026 M 45381 0 0 $0
Donald R. Williams · 1 मई 2017 A · 0 0 $0
Doug Braun · 16 दिसमबर 2015 M 0 0 0 $0

SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S

ईटीएफ स्वामित्व 22 ETFs द्वारा धारित

20

वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।

फंड भार इकाइयाँ तिथि अनुसार स्रोत
VFVA · VANGUARD WELLINGTON FUND 0.11% 45046 SH 19 अगस्त 2026 दैनिक
EBIT · Harbor ETF Trust 0.07% 367 NS 31 जुलाई 2026 N-PORT
IWC · iShares Trust 0.04% 37870 SH 11 सितमबर 2026 दैनिक
VDC · VANGUARD WORLD FUND 0.03% 128565 SH 19 अगस्त 2026 दैनिक
VTWV · VANGUARD SCOTTSDALE FUNDS 0.02% 9639 SH 19 अगस्त 2026 दैनिक
DFSV · Dimensional ETF Trust 0.02% 67386 NS 31 जुलाई 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0.01% 24234 SH 1 अक्टूबर 2026 दैनिक
DFAT · Dimensional ETF Trust 0.01% 67428 NS 31 जुलाई 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0.01% 64278 SH 19 अगस्त 2026 दैनिक
RSSL · Global X Funds 0.01% 5337 NS 31 जुलाई 2026 N-PORT
OMFS · Invesco Exchange-Traded Self-Indexe… 0.01% 1189 SH 1 अक्टूबर 2026 दैनिक
DFAS · Dimensional ETF Trust 0.01% 42099 NS 31 जुलाई 2026 N-PORT
IWM · iShares Trust 0.01% 283783 SH 11 सितमबर 2026 दैनिक
DFAC · Dimensional ETF Trust 0.00% 19278 NS 31 जुलाई 2026 N-PORT
ITOT · iShares Trust 0.00% 22756 SH 11 सितमबर 2026 दैनिक
IWV · iShares Trust 0.00% 3720 SH 3 सितमबर 2026 दैनिक
DFUS · Dimensional ETF Trust 0.00% 1784 NS 31 जुलाई 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.00% 124681 SH 19 अगस्त 2026 दैनिक
VTI · VANGUARD INDEX FUNDS 0.00% 350035 SH 19 अगस्त 2026 दैनिक
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 790 SH 19 अगस्त 2026 दैनिक
IWN · iShares Trust · 101470 SH 11 सितमबर 2026 दैनिक
SMLF · iShares Trust · 22964 SH 11 सितमबर 2026 दैनिक

USNA विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड

21
रेटिंग · 6 विश्लेषक बेचें
मध्यिका लक्ष्य $25.00 +68.7%
0 0.0% मजबूत खरीद
0 0.0% खरीदें
3 50.0% होल्ड
1 16.7% बेचें
2 33.3% मजबूत बिक्री

12-महीने का मूल्य लक्ष्य

1 विश्लेषक · 2026-10-01

माध्य लक्ष्य $25.00 +68.7%

निम्न$25.00 माध्य$25.00 उच्च$25.00

सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी

22

वित्तीय वर्ष के आधार पर, प्रत्येक कंपनी के पिछले वित्तीय वर्ष के अंत के बंद भाव के अनुसार कीमतें।

टिकर मार्केट कैप P/E राजस्व YoY शुद्ध मार्जिन ROE सकल मार्जिन
USNA $355M 33.5 8.3% 1.2% 2.0% 78.3%
EPC $946M 38.4 -1.3% 1.1% 1.7% 41.6%
BRBR $4.39B 21.6 16.1% 9.3% -72.0% 33.3%
HNST $291M -18.4 -1.9% -4.2% -8.8% 33.3%
NUS · 3.0 -14.3% 10.8% 22.0% 69.5%
NAGE $507M 31.8 29.9% 13.4% 24.7% 64.3%
NATR $378M 20.4 5.7% 4.1% 12.0% 72.4%
MED $117M -6.3 -36.0% -4.8% -9.0% 71.3%

मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ

26

उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर फुल फंडामेंटल्स में किसी भी पंक्ति के बगल में + पर क्लिक करें।

आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।

स्रोत: SEC 10-Q अग 13, 2026 को फाइल किया गया